• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤坏死因子-α、趋化因子和白细胞浸润是委内瑞拉马脑炎病毒(VEEV)感染小鼠脑病理学的生物标志物。

Tumour Necrosis Factor-α, Chemokines, and Leukocyte Infiltrate Are Biomarkers for Pathology in the Brains of Venezuelan Equine Encephalitis (VEEV)-Infected Mice.

机构信息

Defence Science and Technology Laboratory, Salisbury SP4 0JQ, UK.

UK Health Security Agency, Salisbury SP4 0JG, UK.

出版信息

Viruses. 2023 May 31;15(6):1307. doi: 10.3390/v15061307.

DOI:10.3390/v15061307
PMID:37376607
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10302690/
Abstract

Venezuelan equine encephalitis virus (VEEV) is a disease typically confined to South and Central America, whereby human disease is characterised by a transient systemic infection and occasionally severe encephalitis, which is associated with lethality. Using an established mouse model of VEEV infection, the encephalitic aspects of the disease were analysed to identify biomarkers associated with inflammation. Sequential sampling of lethally challenged mice (infected subcutaneously) confirmed a rapid onset systemic infection with subsequent spread to the brain within 24 h of the challenge. Changes in inflammatory biomarkers (TNF-α, CCL-2, and CCL-5) and CD45 cell counts were found to correlate strongly to pathology (R>0.9) and present previously unproven biomarkers for disease severity in the model, more so than viral titre. The greatest level of pathology was observed within the olfactory bulb and midbrain/thalamus. The virus was distributed throughout the brain/encephalon, often in areas not associated with pathology. The principal component analysis identified five principal factors across two independent experiments, with the first two describing almost half of the data: (1) confirmation of a systemic Th1-biased inflammatory response to VEEV infection, and (2) a clear correlation between specific inflammation of the brain and clinical signs of disease. Targeting strongly associated biomarkers of deleterious inflammation may ameliorate or even eliminate the encephalitic syndrome of this disease.

摘要

委内瑞拉马脑炎病毒(VEEV)是一种主要局限于南美洲和中美洲的疾病,人类疾病的特征是短暂的全身感染,偶尔会出现严重的脑炎,这与死亡率有关。使用已建立的 VEEV 感染小鼠模型,分析了疾病的脑炎方面,以确定与炎症相关的生物标志物。对致死性挑战的小鼠(皮下感染)进行连续采样证实了快速发生的全身感染,随后在挑战后 24 小时内传播到大脑。炎症生物标志物(TNF-α、CCL-2 和 CCL-5)和 CD45 细胞计数的变化与病理学密切相关(R>0.9),并为该模型中的疾病严重程度提供了以前未证明的生物标志物,比病毒滴度更能说明问题。最大程度的病理学发生在嗅球和中脑/丘脑。病毒分布在整个大脑/脑,通常在与病理学无关的区域。主成分分析在两个独立的实验中确定了五个主要因素,前两个因素描述了近一半的数据:(1)证实了 VEEV 感染引起的全身性 Th1 偏向性炎症反应,(2)大脑特定炎症与疾病临床症状之间的明显相关性。针对有害炎症的强烈相关生物标志物可能会减轻甚至消除这种疾病的脑炎综合征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c16/10302690/517b9abc1589/viruses-15-01307-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c16/10302690/be366345e83d/viruses-15-01307-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c16/10302690/9b688883a858/viruses-15-01307-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c16/10302690/2db7bdf948fd/viruses-15-01307-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c16/10302690/d57ffa1de5fd/viruses-15-01307-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c16/10302690/b7de51d1d8ef/viruses-15-01307-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c16/10302690/f75960e03323/viruses-15-01307-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c16/10302690/ce22db1bf70e/viruses-15-01307-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c16/10302690/dca0c8873867/viruses-15-01307-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c16/10302690/37321a42fe0d/viruses-15-01307-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c16/10302690/517b9abc1589/viruses-15-01307-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c16/10302690/be366345e83d/viruses-15-01307-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c16/10302690/9b688883a858/viruses-15-01307-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c16/10302690/2db7bdf948fd/viruses-15-01307-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c16/10302690/d57ffa1de5fd/viruses-15-01307-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c16/10302690/b7de51d1d8ef/viruses-15-01307-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c16/10302690/f75960e03323/viruses-15-01307-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c16/10302690/ce22db1bf70e/viruses-15-01307-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c16/10302690/dca0c8873867/viruses-15-01307-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c16/10302690/37321a42fe0d/viruses-15-01307-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c16/10302690/517b9abc1589/viruses-15-01307-g010.jpg

相似文献

1
Tumour Necrosis Factor-α, Chemokines, and Leukocyte Infiltrate Are Biomarkers for Pathology in the Brains of Venezuelan Equine Encephalitis (VEEV)-Infected Mice.肿瘤坏死因子-α、趋化因子和白细胞浸润是委内瑞拉马脑炎病毒(VEEV)感染小鼠脑病理学的生物标志物。
Viruses. 2023 May 31;15(6):1307. doi: 10.3390/v15061307.
2
Entry Sites of Venezuelan and Western Equine Encephalitis Viruses in the Mouse Central Nervous System following Peripheral Infection.委内瑞拉马脑炎病毒和西部马脑炎病毒外周感染后在小鼠中枢神经系统中的侵入部位
J Virol. 2016 May 27;90(12):5785-96. doi: 10.1128/JVI.03219-15. Print 2016 Jun 15.
3
Ablation of Programmed -1 Ribosomal Frameshifting in Venezuelan Equine Encephalitis Virus Results in Attenuated Neuropathogenicity.委内瑞拉马脑炎病毒中程序性-1核糖体移码的缺失导致神经致病性减弱。
J Virol. 2017 Jan 18;91(3). doi: 10.1128/JVI.01766-16. Print 2017 Feb 1.
4
Differential host gene responses from infection with neurovirulent and partially-neurovirulent strains of Venezuelan equine encephalitis virus.感染委内瑞拉马脑炎病毒的神经毒力株和部分神经毒力株后宿主基因的差异反应。
BMC Infect Dis. 2017 Apr 26;17(1):309. doi: 10.1186/s12879-017-2355-3.
5
Venezuelan Equine Encephalitis Virus Induces Apoptosis through the Unfolded Protein Response Activation of EGR1.委内瑞拉马脑炎病毒通过激活早期生长反应蛋白1的未折叠蛋白反应诱导细胞凋亡。
J Virol. 2016 Jan 20;90(7):3558-72. doi: 10.1128/JVI.02827-15.
6
Current Understanding of the Molecular Basis of Venezuelan Equine Encephalitis Virus Pathogenesis and Vaccine Development.委内瑞拉马脑炎病毒发病机制和疫苗开发的分子基础的当前认识。
Viruses. 2019 Feb 18;11(2):164. doi: 10.3390/v11020164.
7
Long-term persistence of viral RNA and inflammation in the CNS of macaques exposed to aerosolized Venezuelan equine encephalitis virus.在暴露于气溶胶委内瑞拉马脑炎病毒的猕猴的中枢神经系统中,病毒 RNA 和炎症的长期持续存在。
PLoS Pathog. 2022 Jun 13;18(6):e1009946. doi: 10.1371/journal.ppat.1009946. eCollection 2022 Jun.
8
Toll-like receptor 4 mediates blood-brain barrier permeability and disease in C3H mice during Venezuelan equine encephalitis virus infection.Toll 样受体 4 在委内瑞拉马脑炎病毒感染期间介导 C3H 小鼠血脑屏障通透性和疾病。
Virulence. 2021 Dec;12(1):430-443. doi: 10.1080/21505594.2020.1870834.
9
Host translation shutoff mediated by non-structural protein 2 is a critical factor in the antiviral state resistance of Venezuelan equine encephalitis virus.由非结构蛋白2介导的宿主翻译关闭是委内瑞拉马脑炎病毒抗病毒状态抗性的关键因素。
Virology. 2016 Sep;496:147-165. doi: 10.1016/j.virol.2016.06.005. Epub 2016 Jun 15.
10
Characterization of Brain Inflammation, Apoptosis, Hypoxia, Blood-Brain Barrier Integrity and Metabolism in Venezuelan Equine Encephalitis Virus (VEEV TC-83) Exposed Mice by In Vivo Positron Emission Tomography Imaging.利用体内正电子发射断层扫描成像技术研究委内瑞拉马脑炎病毒(VEEV TC-83)感染小鼠的脑炎症、细胞凋亡、缺氧、血脑屏障完整性和代谢变化特征。
Viruses. 2019 Nov 13;11(11):1052. doi: 10.3390/v11111052.

引用本文的文献

1
Neuropathogenesis of Encephalitic Alphaviruses in Non-Human Primate and Mouse Models of Infection.非人类灵长类动物和小鼠感染模型中脑炎α病毒的神经发病机制
Pathogens. 2025 Feb 14;14(2):193. doi: 10.3390/pathogens14020193.
2
The antiviral BDGR-49 provides protection from lethal, neurotropic Venezuelan equine encephalitis virus intranasal infection in mice.抗病毒药物BDGR-49可保护小鼠免受经鼻感染的致死性嗜神经性委内瑞拉马脑炎病毒的侵害。
J Virol. 2025 Mar 18;99(3):e0167924. doi: 10.1128/jvi.01679-24. Epub 2025 Feb 12.
3
Single-cell and spatiotemporal transcriptomic profiling of brain immune infiltration following Venezuelan equine encephalitis virus infection.

本文引用的文献

1
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.巴瑞替尼治疗 COVID-19 住院患者的疗效(RECOVERY 研究):一项随机、对照、开放标签、平台试验及更新的荟萃分析。
Lancet. 2022 Jul 30;400(10349):359-368. doi: 10.1016/S0140-6736(22)01109-6.
2
Efficacy of Western, Eastern, and Venezuelan Equine Encephalitis (WEVEE) Virus-Replicon Particle (VRP) Vaccine against WEEV in a Non-Human Primate Animal Model.西方马脑炎病毒、东方马脑炎病毒和委内瑞拉马脑炎病毒(WEVEE)病毒复制子颗粒(VRP)疫苗对非人灵长类动物模型中 WEEV 的效力。
Viruses. 2022 Jul 8;14(7):1502. doi: 10.3390/v14071502.
3
委内瑞拉马脑炎病毒感染后脑免疫浸润的单细胞和时空转录组分析
Front Immunol. 2024 Dec 19;15:1497839. doi: 10.3389/fimmu.2024.1497839. eCollection 2024.
4
Neurological manifestations of encephalitic alphaviruses, traumatic brain injuries, and organophosphorus nerve agent exposure.脑炎型甲病毒、创伤性脑损伤和有机磷神经毒剂暴露的神经学表现。
Front Neurosci. 2024 Dec 13;18:1514940. doi: 10.3389/fnins.2024.1514940. eCollection 2024.
5
Requirement for Fc effector function is overcome by binding potency for broadly reactive anti-alphavirus antibodies.对广泛反应性抗甲病毒抗体的结合效力克服了对Fc效应子功能的需求。
bioRxiv. 2024 Nov 3:2024.11.03.619087. doi: 10.1101/2024.11.03.619087.
EGR1 Upregulation during Encephalitic Viral Infections Contributes to Inflammation and Cell Death.
脑炎病毒感染期间 EGR1 的上调导致炎症和细胞死亡。
Viruses. 2022 Jun 2;14(6):1210. doi: 10.3390/v14061210.
4
Safety and immunogenicity of a trivalent virus-like particle vaccine against western, eastern, and Venezuelan equine encephalitis viruses: a phase 1, open-label, dose-escalation, randomised clinical trial.三价病毒样颗粒疫苗预防西、东、委内瑞拉马脑炎病毒的安全性和免疫原性:一项 1 期、开放性标签、剂量递增、随机临床试验。
Lancet Infect Dis. 2022 Aug;22(8):1210-1220. doi: 10.1016/S1473-3099(22)00052-4. Epub 2022 May 11.
5
Neutralizing antibodies protect mice against Venezuelan equine encephalitis virus aerosol challenge.中和抗体可保护小鼠免受委内瑞拉马脑炎病毒气溶胶攻击。
J Exp Med. 2022 Apr 4;219(4). doi: 10.1084/jem.20212532. Epub 2022 Mar 17.
6
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.COVID-19 患者住院期间使用阿司匹林(RECOVERY):一项随机、对照、开放标签、平台试验。
Lancet. 2022 Jan 8;399(10320):143-151. doi: 10.1016/S0140-6736(21)01825-0. Epub 2021 Nov 17.
7
The JAK1/2 inhibitor baricitinib suppresses eosinophil effector function and restricts allergen-induced airway eosinophilia.JAK1/2 抑制剂巴瑞替尼抑制嗜酸性粒细胞效应功能,并限制变应原诱导的气道嗜酸性粒细胞增多。
Biochem Pharmacol. 2021 Oct;192:114690. doi: 10.1016/j.bcp.2021.114690. Epub 2021 Jul 16.
8
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.托珠单抗治疗 COVID-19 住院患者的疗效(RECOVERY):一项随机、对照、开放标签、平台试验。
Lancet. 2021 May 1;397(10285):1637-1645. doi: 10.1016/S0140-6736(21)00676-0.
9
Robust COX-2-mediated prostaglandin response may drive arthralgia and bone destruction in patients with chronic inflammation post-chikungunya.在感染基孔肯雅热后的慢性炎症患者中,COX-2 介导的前列腺素反应可能会导致关节痛和骨破坏。
PLoS Negl Trop Dis. 2021 Feb 17;15(2):e0009115. doi: 10.1371/journal.pntd.0009115. eCollection 2021 Feb.
10
Toll-like receptor 4 mediates blood-brain barrier permeability and disease in C3H mice during Venezuelan equine encephalitis virus infection.Toll 样受体 4 在委内瑞拉马脑炎病毒感染期间介导 C3H 小鼠血脑屏障通透性和疾病。
Virulence. 2021 Dec;12(1):430-443. doi: 10.1080/21505594.2020.1870834.